Page 54 - Quest Diagnostics News Today

Work has apparently stopped on construction of a new $227 million Wadley Regional Medical Center facility in TEXarkana.

/PRNewswire/ -- According to Ariztons latest research report, the U.S. clinical laboratory tests market will grow at a CAGR of 2.17% from 2023 to 2029. To...

Here are the biggest calls on Wall Street on Wednesday.

Worried about a possible exposure to syphilis? These syphilis tests can give you the answers you need in the privacy of your home.

Argent Trust Co cut its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 2.1% during the 3rd quarter, Holdings Channel reports. The fund owned 34,926 shares of the medical research company’s stock after selling 765 shares during the period. Argent Trust Co’s holdings in Quest Diagnostics were worth $4,256,000 as of […]

Argent Trust Co decreased its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 2.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 34,926 shares of the medical research company’s stock after selling 765 shares during the […]

Quest Diagnostics (NYSE:DGX – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 8.600-8.900 for the period, compared to the consensus EPS estimate of 8.990. The company issued revenue guidance of $9.4 billion-$9.5 billion, compared to the consensus revenue estimate of $9.4 billion. Quest Diagnostics also updated […]

Oppenheimer & Co. Inc. trimmed its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 0.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 49,841 shares of the medical research company’s stock after selling 456 shares during the quarter. […]

Oppenheimer & Co. Inc. cut its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 0.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 49,841 shares of the medical research company’s stock after selling 456 shares […]

Quest Diagnostics (NYSE:DGX – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 8.600-8.900 for the period, compared to the consensus earnings per share estimate of 8.990. The company issued revenue guidance of $9.4 billion-$9.5 billion, compared to the consensus revenue estimate of $9.4 billion. […]